BrainXell

Madison, United States

BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery.

$13.2M raised

Sep 2021

Venture - Series Unknown

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BrainXell

How much funding has BrainXell raised?

BrainXell has raised $13.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2021.

Where is BrainXell headquartered?

BrainXell is headquartered in Madison, United States.

What does BrainXell do?

BrainXell provides a range of high-purity, iPSC-derived human neurons for research and development with a focus on drug discovery.

What stage is BrainXell at?

BrainXell is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 13, 2021.

MLA

"BrainXell — Funding & Investors." VCBacked, September 13, 2021, https://www.vcbacked.co/company/brainxell. Accessed July 2, 2026.

APA

VCBacked. (2021). BrainXell — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/brainxell

Wikipedia (cite web)

{{cite web |title=BrainXell — Funding & Investors |url=https://www.vcbacked.co/company/brainxell |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 13, 2021.